Clinical Trial to Evaluate the Efficacy, Tolerance and Acceptability of URGO Dressing vs a Hydrofibre in the Local Management of Venous or Predominantly Venous Mixed Leg Ulcers.

Exclusion Criteria

• •Female patient of child-bearing potential who has no effective means of contraception
• •Patient who is pregnant or breastfeeding
• •Patient taking part in another therapeutic trial
• •Patient with hypersensitivity to one of the components of the trial dressing or a known allergy to carboxymethylcellulose (hydrocolloid)
• •Patient with a serious general pathological condition who, it may be feared, might discontinue participation in the trial before the six weeks of treatment
• •Patient with an evolving neoplastic condition, treated by radiotherapy, chemotherapy or hormone therapy
• •Patient with a systemic infection not controlled by suitable antibiotic treatment
• •Patient who, during the 3 months before inclusion, presented a deep vein thrombosis
• •Ulcer where its surface is totally or partially covered by black necrotic plaque
• •Ulcer which is clinically infected
• •Ulcer requiring surgical treatment or for which surgery is programmed during the six weeks following inclusion
• •Malignant ulcer